“celgene” Archives

in
Entry Author Date Location
Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs 09/24/20 Boston
Gilead Sciences Places $120M Bet on a Jounce Therapeutics Cancer Drug 09/01/20 San Francisco
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Bristol Myers Squibb to Splash Out $475M on Dragonfly Immunotherapy 08/17/20 New York
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs 06/05/20 Boston
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs 05/29/20 Boston
BCMA Delay: FDA Refuses Review of Bristol Drug, Asks for More Info 05/13/20 New York
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Celularity to Test Natural Killer Cell Therapy for Cancer Against COVID 04/02/20 National
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch 03/26/20 New York
Regenacy Pharma Raises $30M for Nerve Function Restoring Treatments 03/25/20 Boston
Silverback Therapeutics Adds $79M to Test HER2+ Tumor-Targeting Drug 03/11/20 Seattle
New Meds Set to Reshape US CNS and Oncology Markets 02/18/20 National
Bristol-Myers, BioMotiv Pact Leads to a New Fibrosis-Focused Startup 02/04/20 New York
Third Time’s the Charm as Acceleron Drug Shows Early Promise in PAH 01/28/20 Boston
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto 01/07/20 San Diego
Perceptive Unveils New $210M Fund to Invest in Early-Stage Biotechs 12/10/19 New York
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
Anemia Drug From Acceleron Pharma and Celgene Wins FDA Approval 11/08/19 New York
Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer 10/21/19 Boston
Plexium Debuts With $28M and a New Take on Protein Degradation Drugs 10/17/19 San Diego
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug 10/15/19 Boston
Gilliland to Step Down as Head of Fred Hutch in 2020 09/17/19 Seattle
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight 08/28/19 New York
Celgene to Sell Blockbuster Drug to Amgen for $13B to Close BMS Deal 08/26/19 New York
Page 1 of 19 next page »